New scan could spot hidden cancers in the belly

NCT ID NCT07219238

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new PET/CT scan using a radioactive tracer called GEH300079 to detect peritoneal carcinomatosis—cancer that has spread to the lining of the abdomen—in people with colorectal, stomach, ovarian, or pancreatic cancer. About 175 adults with known or suspected spread will receive the scan before planned surgery. The goal is to see if this scan is more accurate than standard imaging at finding cancer in different abdominal regions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
GEH300079 (68Ga) injection (a radioactive tracer used in PET/CT imaging)
What this could lead to
If successful, this could provide a more accurate, non-invasive way to detect cancer spread in the abdomen, helping doctors plan better surgeries.
What could go wrong
This is an early-to-mid-stage trial with only 175 participants, so results may not apply to all patients. The scan may not be more accurate than current methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • BAMF Health

    NOT_YET_RECRUITING

    Grand Rapids, Michigan, 49503, United States

  • Karolinska Universitetssjukhuset

    RECRUITING

    Stockholm, 17176, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.